Commonly reported side effects of axitinib include: headache, hypertension, hypothyroidism, increased serum alanine aminotransferase, and proteinuria.  See below for a comprehensive list of adverse effects.
The most common adverse reactions included diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, hand-foot syndrome, decreased weight, vomiting, asthenia, and constipation.
Very common (10% or more): Hypertension (40%)Common (1% to 10%): Deep vein thrombosis, cardiac failure events, venous thromboembolic events, arterial thromboembolic events, myocardial infarctionRare (less than 0.1%): Hypertensive crisis
Hypertension has been reported in up to 40% or patients, with grade 3 or 4 hypertension and hypertensive crisis in 16% and less than 1% of those patients, respectively.  The median onset time for hypertension was within the first month, with increases observed as early as 4 days after starting the drug.  Less than 1% of patients discontinued therapy due to hypertension.  Arterial thromboembolic events including transient ischemic attacks, cerebrovascular accidents, myocardial infarctions, and retinal artery occlusions were reported in 2% of patients (17 of 715) and venous thromboembolic events including pulmonary embolism, deep vein thrombosis, retinal vein occlusion, and retinal vein thrombosis were reported in 3% of patients (22 of 715).Cardiac failure was reported in 2% (6 of 359) patients; grade 3 or 4 in 1% (2 of 359).
Very common (10% or more): Headache (15%), dysgeusia (11%)Common (1% to 10%): Dizziness, transient ischemic attackRare (less than 0.1%): Posterior reversible encephalopathy syndromeFrequency not reported: Cerebrovascular accidents
Arterial thromboembolic events including transient ischemic attacks, cerebrovascular accidents, myocardial infarctions, and retinal artery occlusions were reported in 2% of patients (17 of 715).  Three cases of reversible posterior leukoencephalopathy syndrome (RPLS), also known as posterior reversible encephalopathy syndrome (PRES) were reported during clinical trials.
Arterial thromboembolic events including transient ischemic attacks, cerebrovascular accidents, myocardial infarctions, and retinal artery occlusions were reported in 2% of patients (17 of 715).  Venous thromboembolic events including pulmonary embolism, deep vein thrombosis, retinal vein occlusion, and retinal vein thrombosis were reported in 3% of patients (22 of 715).
Common (1% to 10%): Retinal vein occlusion/thrombosis Frequency not reported: Retinal artery occlusions
Very common (10% or more): Diarrhea (55%), nausea (32%), vomiting (24%), constipation (20%), stomatitis (15%), abdominal pain (14%), increased lipase (27%), increased amylase (25%) Common (1% to 10%): Upper abdominal pain, hemorrhoids, glossodynia, rectal hemorrhage, dyspepsia, flatulenceUncommon (0.1% to 1%): Gastrointestinal perforation, fistulasFrequency not reported: Lower gastrointestinal hemorrhage, melena
Very common (10% or more): Transaminase increases (20% to 22%), alkaline phosphatase increases (30%), hypoalbuminemia (15%)
Very common (10% or more): Increased creatinine (55%), proteinuria (11%)Common (1% to 10%): Hematuria, renal failure
Very common (10% or more): Fatigue (39%), asthenia (21%), Common (1% to 10%): Tinnitus
Very common (10% or more): Hand-foot syndrome (27%), rash (13%) Common (1% to 10%): Pruritus, alopecia, erythema, dry skin
Hypothyroidism was reported in 20.9% of patients and hyperthyroidism in 1.1%.  Among patients with TSH levels less than 5 micromoles/mL prior to treatment, elevations to greater 10 micromoles/mL occurred in greater than 32.2%
Very common (10% or more): Hypothyroidism (20%), Common (1% to 10%): Hyperthyroidism, increased thyroid stimulating hormone (TSH)
Very common (10% or more): Decreased hemoglobin (35%), decreased lymphocytes (33%) decreased platelets (15%), WBC decreased (11%) Common (1% to 10%): Anemia, polycythemia, increased hemoglobinUncommon (0.1% to 1%): Neutropenia, leukopenia
Very common (10% or more): Decreased appetite (34%), weight loss (25%), decreased bicarbonate (44%), hypocalcemia (39%), hyperglycemia (28%), hypernatremia (17%), hyperkalemia (15%), hypoglycemia (11%), hyponatremia (13%), hypophosphatemia (13%) Common (1% to 10%): Dehydration
Very common (10% or more): Arthralgia (15%), extremity pain (14%), Common (1% to 10%): Myalgia,
Very common (10% or more): Dysphonia (31%), cough (15%), mucosal inflammation (15%), dyspnea (15%) Common (1% to 10%): Epistaxis, pulmonary embolism, hemoptysis
Venous thromboembolic events including pulmonary embolism, deep vein thrombosis, retinal vein occlusion, and retinal vein thrombosis were reported in 3% of patients (22 of 715).
Abdominal or stomach pain
bleeding gums
bloody nose
blurred vision
cloudy urine
confusion
constipation
coughing up blood
decreased urination
depressed mood
difficult or labored breathing
difficulty with swallowing
dizziness
dry mouth
dry skin and hair
fainting
feeling cold
hair loss
hoarseness or husky voice
incoherent speech
increased menstrual flow or vaginal bleeding
increased urination
lightheadedness
loss of appetite
metallic taste
muscle cramps and stiffness
muscle weakness
nausea
nervousness
nosebleeds
paralysis
pounding in the ears
rapid breathing
red or black, tarry stools
red or dark brown urine
redness, swelling, or pain of the skin
scaling of the skin on the hands and feet
slow or fast heartbeat
sunken eyes
thirst
tightness in the chest
tingling of the hands and feet
ulceration of the skin
unusual tiredness or weakness
vomiting
weight gain or loss
wrinkled skin
Anxiety
bleeding from the gums or nose
bleeding from the rectum
bloody, black or tarry stools
change in vision
chest pain or discomfort
extreme drowsiness
eye pain
heartburn
inability to speak
indigestion
numbness or tingling in the face, arms, hands, or legs
pain in the chest, groin, or legs
pain or discomfort in the arms, jaw, back, or neck
pain, redness, or swelling in the arm or leg
pale skin
ringing in the ears
seizures
sensitivity to heat
severe headaches of sudden onset
severe stomach pain, cramping, or burning
slurred speech
sudden loss of coordination
sudden onset of slurred speech
sudden shortness of breath or troubled breathing
sudden vision changes
sweating
temporary blindness
trouble sleeping
trouble speaking, thinking, or walking
troubled breathing with exertion
uncomfortable swelling around the anus
unusual bleeding or bruising
vomiting of material that looks like coffee grounds
weakness in the arm or leg on one side of the body
Belching
change in taste
cough
cracked lips
decreased appetite
diarrhea
difficulty with moving
itching skin or rash
joint pain
lack or loss of strength
loss of taste
muscle aches or pain
pain in the arms or legs
sore throat
sores, ulcers, or white spots on the lips, tongue, or inside the mouth
stomach discomfort or upset
swelling or inflammation of the mouth
swollen joints
upper stomach pain
voice changes
Burning sensation of the tongue
continuous ringing or buzzing or other unexplained noise in the ears
flushing or redness of the skin
hearing loss
thinning of the hair
unusually warm skin